Division for Reproductive Endocrinology and the Paediatric Endocrinology Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Reprod Biol Endocrinol. 2012 Jan 18;10:3. doi: 10.1186/1477-7827-10-3.
Prostaglandins are important for female reproduction. Prostaglandin-E2 acts via four different receptor subtypes, EP1, EP2, EP3 and EP4 whereas prostaglandin-F2alpha acts through FP. The functions of prostaglandins depend on the expression of their receptors in different uterine cell types. Our aim was to investigate the expression of EPs and FP in rat uterus and to identify the regulation by estradiol, progesterone and estrogen receptor (ER) selective agonists.
We performed four different rat experiments involving treatments with estradiol, progesterone and ER agonists. Real-time PCR and immunohistochemistry were employed to evaluate receptor expression.
Our results showed that all mRNAs and proteins of EPs and FP are expressed in the rat uterus. The expression pattern and intensity of immunostaining vary between different cell types and treatments. The mRNA expression of all EPs and FP are downregulated by estradiol and the ERalpha specific agonist PPT, whereas the ERbeta specific agonist DPN downregulates only EP2 and EP4. The protein expression however, showed an increase in EP2 and EP3 after estradiol treatment. When treated with estradiol and progesterone in combination, the expressions of EP1 and EP3 are upregulated.
Regulation of EPs and FP expression by estradiol appears to be mainly modulated via ERalpha for EP1, EP3 and FP, while EP2 and EP4 also are affected by the ERbeta selective ligand. Our immunohistochemical data shows a cell specific regulation of prostaglandin receptors under the influence of ovarian steroids, where EP2 is estrogen regulated in all uterine tissues examined. EP1 and EP3 are upregulated by the combination of estradiol and progesterone. Thus, our observations indicate that estradiol and progesterone regulate the mRNA and protein expression of EPs and FP in a receptor and tissue specific way.
前列腺素对女性生殖功能至关重要。前列腺素 E2 通过四个不同的受体亚型 EP1、EP2、EP3 和 EP4 发挥作用,而前列腺素 F2alpha 通过 FP 发挥作用。前列腺素的功能取决于其在不同子宫细胞类型中的受体表达。我们的目的是研究大鼠子宫中 EP 和 FP 的表达,并确定其受雌二醇、孕酮和雌激素受体(ER)选择性激动剂的调节。
我们进行了四项不同的大鼠实验,涉及雌二醇、孕酮和 ER 激动剂的处理。采用实时 PCR 和免疫组织化学方法评估受体表达。
我们的结果表明,大鼠子宫中表达所有 EP 和 FP 的 mRNAs 和蛋白。不同细胞类型和处理之间的免疫染色表达模式和强度不同。所有 EP 和 FP 的 mRNA 表达均受雌二醇和 ERalpha 特异性激动剂 PPT 下调,而 ERbeta 特异性激动剂 DPN 仅下调 EP2 和 EP4。然而,蛋白表达在雌二醇处理后显示 EP2 和 EP3 增加。当用雌二醇和孕酮联合处理时,EP1 和 EP3 的表达上调。
雌二醇对 EP 和 FP 表达的调节似乎主要通过 ERalpha 调节 EP1、EP3 和 FP,而 EP2 和 EP4 也受 ERbeta 选择性配体的影响。我们的免疫组织化学数据显示,卵巢类固醇对前列腺素受体具有细胞特异性调节作用,其中 EP2 在所有检查的子宫组织中均受雌激素调节。EP1 和 EP3 受雌二醇和孕酮的联合上调。因此,我们的观察表明,雌二醇和孕酮以受体和组织特异性方式调节 EP 和 FP 的 mRNA 和蛋白表达。